A detailed history of Steward Partners Investment Advisory, LLC transactions in Ocugen, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 405 shares of OCGN stock, worth $400. This represents 0.0% of its overall portfolio holdings.

Number of Shares
405
Previous 405 -0.0%
Holding current value
$400
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 02, 2022

BUY
$2.34 - $4.72 $947 - $1,911
405 New
405 $1,000
Q4 2021

Feb 08, 2022

SELL
$4.38 - $15.67 $65 - $235
-15 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$5.52 - $15.68 $3,367 - $9,564
-610 Reduced 97.6%
15 $0
Q1 2021

May 14, 2021

BUY
$1.66 - $15.81 $1,037 - $9,881
625 New
625 $4,000

Others Institutions Holding OCGN

About Ocugen, Inc.


  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $214M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Steward Partners Investment Advisory, LLC Portfolio

Follow Steward Partners Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.